1 Grayson, M. Bladder cancer. Nature 551, S33, doi:10.1038/551S33a (2017).
2 Berdik, C. Unlocking bladder cancer. Nature 551, S34-S35, doi:10.1038/551S34a (2017).
3 Stenzl, A. et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 55, 815-825, doi:10.1016/j.eururo.2009.01.002 (2009).
4 Hainer, S. J. et al. Suppression of pervasive noncoding transcription in embryonic stem cells by esBAF. Genes Dev 29, 362-378, doi:10.1101/gad.253534.114 (2015).
5 Spornraft, M., Kirchner, B., Pfaffl, M. W. & Riedmaier, I. Comparison of the miRNome and piRNome of bovine blood and plasma by small RNA sequencing. Biotechnol Lett 37, 1165-1176, doi:10.1007/s10529-015-1788-2 (2015).
6 Fatica, A. & Bozzoni, I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15, 7-21, doi:10.1038/nrg3606 (2014).
7 Kung, J. T., Colognori, D. & Lee, J. T. Long noncoding RNAs: past, present, and future. Genetics 193, 651-669, doi:10.1534/genetics.112.146704 (2013).
8 Shen, X. H., Qi, P. & Du, X. Long non-coding RNAs in cancer invasion and metastasis. Mod Pathol 28, 4-13, doi:10.1038/modpathol.2014.75 (2015).
9 Li, X., Zhang, L., Song, P., Xu, J. & Li, G. Long non-coding RNA PANDAR promotes melanoma cell invasion through regulating epithelial-mesenchymal transition. Int J Clin Exp Pathol 11, 2430-2439 (2018).
10 Liang, W. C. et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 6, 22513-22525, doi:10.18632/oncotarget.4154 (2015).
11 Luo, J. et al. LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway. Oncol Lett 14, 5556-5562, doi:10.3892/ol.2017.6886 (2017).
12 Eliseeva, I. A., Kim, E. R., Guryanov, S. G., Ovchinnikov, L. P. & Lyabin, D. N. Y-box-binding protein 1 (YB-1) and its functions. Biochemistry (Mosc) 76, 1402-1433, doi:10.1134/S0006297911130049 (2011).
13 Prabhu, L. et al. Role of post-translational modification of the Y box binding protein 1 in human cancers. Genes Dis 2, 240-246, doi:10.1016/j.gendis.2015.05.001 (2015).
14 Shibata, T. et al. Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer. Oncotarget 9, 37216-37228, doi:10.18632/oncotarget.26469 (2018).
15 Zhang, E. et al. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol 19, 154, doi:10.1186/s13059-018-1523-0 (2018).
16 Nikhil, K. et al. Aurora Kinase A-YBX1 Synergy Fuels Aggressive Oncogenic Phenotypes and Chemoresistance in Castration-Resistant Prostate Cancer. Cancers (Basel) 12, doi:10.3390/cancers12030660 (2020).
17 Liang, C. et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci 110, 166-179, doi:10.1111/cas.13875 (2019).
18 Zhou, L. L. et al. High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma. Exp Cell Res 361, 126-134, doi:10.1016/j.yexcr.2017.10.009 (2017).
19 Bao, Z. et al. LncRNADisease 2.0: an updated database of long non-coding RNA-associated diseases. Nucleic Acids Res 47, D1034-D1037, doi:10.1093/nar/gky905 (2019).
20 Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42, D92-97, doi:10.1093/nar/gkt1248 (2014).
21 Cook, K. B., Kazan, H., Zuberi, K., Morris, Q. & Hughes, T. R. RBPDB: a database of RNA-binding specificities. Nucleic Acids Res 39, D301-308, doi:10.1093/nar/gkq1069 (2011).
22 Xu, L., Li, H., Wu, L. & Huang, S. YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer. Oncotarget 8, 65946-65956, doi:10.18632/oncotarget.19583 (2017).
23 Shiota, M. et al. Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells. BJU Int 108, E142-149, doi:10.1111/j.1464-410X.2010.09810.x (2011).
24 Dhillon, J. et al. The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells. Oncogene 29, 6294-6300, doi:10.1038/onc.2010.365 (2010).
25 To, K. et al. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res 70, 2840-2851, doi:10.1158/0008-5472.CAN-09-3155 (2010).
26 Klaus, A. & Birchmeier, W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8, 387-398, doi:10.1038/nrc2389 (2008).
27 MacDonald, B. T., Tamai, K. & He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17, 9-26, doi:10.1016/j.devcel.2009.06.016 (2009).
28 Fan, Y. et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J 281, 1750-1758, doi:10.1111/febs.12737 (2014).
29 Zhu, X., Li, Y., Zhao, S. & Zhao, S. LSINCT5 activates Wnt/beta-catenin signaling by interacting with NCYM to promote bladder cancer progression. Biochem Biophys Res Commun 502, 299-306, doi:10.1016/j.bbrc.2018.05.076 (2018).
30 Wang, J. et al. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis. J Pharmacol Exp Ther 372, 237-247, doi:10.1124/jpet.119.262949 (2020).
31 Kosnopfel, C., Sinnberg, T. & Schittek, B. Y-box binding protein 1--a prognostic marker and target in tumour therapy. Eur J Cell Biol 93, 61-70, doi:10.1016/j.ejcb.2013.11.007 (2014).
32 Dang, C. V. A Time for MYC: Metabolism and Therapy. Cold Spring Harb Symp Quant Biol 81, 79-83, doi:10.1101/sqb.2016.81.031153 (2016).
33 Guo, J. et al. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/beta-catenin signaling pathway. Cancer Cell Int 19, 312, doi:10.1186/s12935-019-1010-z (2019).
34 Simon, M. D. et al. The genomic binding sites of a noncoding RNA. Proc Natl Acad Sci U S A 108, 20497-20502, doi:10.1073/pnas.1113536108 (2011).